Giant-cell arteritis: ophthalmic and systemic considerations.
D000367:Age Factors; D000368:Aged; D001157:Arterial Occlusive Diseases / Q000209:etiology; D001167:Arteritis / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy; D001706:Biopsy; D001766:Blindness / Q000209:etiology; D001799:Blood Sedimentation; D003937:Diagnosis, Differential; D004692:Endarteritis / Q000473:pathology; D005128:Eye Diseases / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D005260:Female; D005451:Fluorescein Angiography; D005654:Fundus Oculi; D013700:Giant Cell Arteritis / Q000473:pathology; D006801:Humans; D008875:Middle Aged; D010211:Papilledema / Q000209:etiology; D011111:Polymyalgia Rheumatica / Q000209:etiology; D011241:Prednisone / Q000627:therapeutic use; D012171:Retinal Vessels
D011241:Prednisone